Find a trial

POPSTAR II

Lu-PSMA for Oligometastatic Prostate Cancer Treated With Stereotactic Ablative Radiotherapy

Locations Epworth Richmond, Epworth Freemasons, Moreland, Holmesglen, Mulgrave

Diagnosis Prostate cancer

78278343PCR1003

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer

Locations Adelaide

Diagnosis Prostate cancer

WOMBAT / ANZUP 2201

Evaluating the efficacy of bipolar androgen therapy in extending metastasis-free survival in patients with M0 castrate-resistant prostate cancer with prostate specific antigen progression but not radiological or clinical progression on darolutamide

Locations Chermside

Diagnosis Prostate cancer

TUTELA / TUT-001A

To evaluate the feasibility of inserting Tutelix™ to reduce the dose of radiation to the rectum in men undergoing radiotherapy

Locations Gold Coast University Hospital

Diagnosis Prostate cancer

ANZadapt / ANZUP 2101

Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC

Locations Adelaide

Diagnosis Prostate cancer

KLK2-comPAS / 78278343PCR3001

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Locations Adelaide

Diagnosis Prostate cancer